Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials
Publication
, Journal Article
Khan, MS; Kristensen, SL; Vaduganathan, M; Kober, L; Abraham, WT; Desai, AS; Solomon, SD; Swedberg, K; Dickstein, K; Zile, MR; Packer, M ...
Published in: American Heart Journal
July 2021
Duke Scholars
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
July 2021
Volume
237
Start / End Page
45 / 53
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Khan, M. S., Kristensen, S. L., Vaduganathan, M., Kober, L., Abraham, W. T., Desai, A. S., … Butler, J. (2021). Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. American Heart Journal, 237, 45–53. https://doi.org/10.1016/j.ahj.2021.02.015
Khan, Muhammad Shahzeb, Soren Lund Kristensen, Muthiah Vaduganathan, Lars Kober, William T. Abraham, Akshay S. Desai, Scott D. Solomon, et al. “Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.” American Heart Journal 237 (July 2021): 45–53. https://doi.org/10.1016/j.ahj.2021.02.015.
Khan MS, Kristensen SL, Vaduganathan M, Kober L, Abraham WT, Desai AS, et al. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. American Heart Journal. 2021 Jul;237:45–53.
Khan, Muhammad Shahzeb, et al. “Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.” American Heart Journal, vol. 237, Elsevier BV, July 2021, pp. 45–53. Crossref, doi:10.1016/j.ahj.2021.02.015.
Khan MS, Kristensen SL, Vaduganathan M, Kober L, Abraham WT, Desai AS, Solomon SD, Swedberg K, Dickstein K, Zile MR, Packer M, McMurray JJV, Butler J. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials. American Heart Journal. Elsevier BV; 2021 Jul;237:45–53.
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
July 2021
Volume
237
Start / End Page
45 / 53
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology